Clinical Trial Update: Niraparib in Tumors Metastatic to the CNS [Phase 2]

View source ↗

Summary

Niraparib is being studied in a Phase 2 trial for tumors metastatic to the central nervous system. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Cancer, Central Nervous System Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING